Chronic infection with Pseudomonas aeruginosa (Pa) in patients with Cystic Fibrosis (CF) is associated with increased morbidity and mortality. Respiratory muscle function can be assessed by maximal inspiratory pressure (Pi max ), maximal expiratory pressure (Pe max ) and pressure-time index of the respiratory muscles (PTI mus ). Objectives: To compare respiratory muscle function by measurement of Pi max , Pe max and PTI mus between CF patients at different stages of Pa infection in a large cohort comprising of children and young adults. Methods: We investigated the differences in maximal respiratory pressures, PTI mus and anthropometric indices in different stages of Pa infection according to the Leeds criteria (never infected, free of infection, intermittent infection, chronic infection). FEV 1 , FVC, MEF 25−75 , Body Mass Index, Upper Arm Muscle Area (UAMA), Pi max , Pe max and PTI mus were assessed in 122 CF patients who formed four groups matched for age and gender according to the different stages of Pa infection. Results: Median Pi max was significantly lower in CF patients with chronic Pa infection compared to patients that were never infected, free of infection or intermittently infected. Median PTI mus was significantly increased in CF patients with chronic Pa infection compared to patients that were free of infection. Multivariate logistic regression revealed state of infection as a significant determinant of PTI mus independently of UAMA and FEV 1 . Conclusion: CF patients with chronic Pa infection exhibit impaired respiratory muscle function and decreased inspiratory muscle strength. Chronic Pa infection might independently impact on respiratory muscle function in patients with CF.
Objectives: P. aeruginosa is the primary cause for pulmonary destruction and premature death in CF patients. Therefore it is of highest interest to prevent airway colonization with the pathogen that is ubiquitously present in water. Whereas it is frequently detected in dental unit waterlines with proven transmission to CF patients, risks of acquisition within otorhinolaryngological treatment have not yet been discussed, although some perils could be comparable. We present five CF patients who primarily acquired P. aeruginosa around otorhinolaryngological surgery (4) or dentist treatment (1). Additionally, we discuss risks and preventive strategies for CF patients undergoing otorhinological treatment. Altogether, risks range from contact to pathogen carriers in waiting rooms to instrumentation, suction, drilling or flushing fluid in oral and sinonasal areas, when droplets containing pathogens can be nebulized into CF airways. Postsurgically mucosal damage impairs sinonasal mucociliary clearance, which additionally to debridement and crusts facilitates pathogens to clinch and proliferate. Thus, otorhinolaryngological surgery in CF must be linked to repeated assessment of pathogen colonization, together with cleansing, anti-inflammatory and antibiotic therapy. Further studies must elaborate, whether all operated CF patients, independent from pre-surgical colonization status, would routinely require antipseudomonal treatment, including nasal lavages containing antibiotics as presented in a series of protocols. Altogether, we must bring up attention on this probably underestimated risk within CF therapy and postulate structured prevention protocols, available to all patients. 
